The Gross Margin of Hainan Huluwa Pharmaceutical Group Co Ltd (605199.SS) is 47.37%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 47.37% |
2023-12-31 | 53.14% |
2022-12-31 | 57.47% |
2021-12-31 | 59.63% |
2020-12-31 | 61.75% |
2019-12-31 | 61.86% |
2018-12-31 | 61.25% |
2017-12-31 | 48.34% |